Targeting the mevalonate pathway in multiple myeloma

被引：3
|
作者：
van der Spek, Ellen [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 03期
关键词：
Multiple myeloma; Mevalonate pathway; Plasma cell lines; FPP; GGPP; CELL-LINES; DRUG-RESISTANCE; PLASMA-CELLS; APOPTOSIS; SIMVASTATIN; INHIBITOR; SURVIVAL; PROTEIN; GERANYLGERANYLATION; FARNESYLATION;
D O I：
10.1016/j.leukres.2009.07.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [41] Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma.
    Yarde, Danielle N.
    Oliveira, Vasco
    Mathews, Linda
    Wang, Xingyu
    Villagra, Alejandro
    Boulware, David
    Shain, Kenneth H.
    Hazlehurst, Lori A.
    Alsina, Melissa
    Chen, Dung-Tsa
    Beg, Amer A.
    Dalton, William S.
    CANCER RESEARCH, 2009, 69 (24) : 9367 - 9375
  • [42] Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
    Arghya Ray
    Yan Song
    Ting Du
    Yu-Tzu Tai
    Dharminder Chauhan
    Kenneth C. Anderson
    Leukemia, 2020, 34 : 567 - 577
  • [43] Targeting the protein degradation pathway in multiple myeloma with synergistic, selective small molecules.
    Bradner, J
    Shen, JP
    Greenberg, E
    Hideshima, T
    Anderson, KC
    Schreiber, SL
    BLOOD, 2005, 106 (11) : 694A - 694A
  • [44] Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
    Ray, Arghya
    Song, Yan
    Du, Ting
    Tai, Yu-Tzu
    Chauhan, Dharminder
    Anderson, Kenneth C.
    LEUKEMIA, 2020, 34 (02) : 567 - 577
  • [45] Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
    Laka, Kagiso
    Makgoo, Lilian
    Mbita, Zukile
    FRONTIERS IN GENETICS, 2022, 13
  • [46] Targeting myeloma cell growth factors in multiple myeloma
    Klein, B.
    Hose, D.
    Moreaux, J.
    De Vos, J.
    Jourdan, M.
    Sprinsky, A. C.
    Jourdan, E.
    Reme, T.
    Mahtouk, K.
    Goldschmidt, H.
    Rossi, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 43 - 44
  • [47] Strategies to enhance epidermal growth factor inhibition: Targeting the mevalonate pathway
    Dimitroulakos, Jim
    Lorimer, Ian A.
    Goss, Glenwood
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4426S - 4431S
  • [48] Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor
    Mantha, AJ
    Hanson, JEL
    Goss, G
    Lagarde, AE
    Lorimer, IA
    Dimitroulakos, J
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2398 - 2407
  • [49] Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
    Sano, Yusuk
    Kuwabara, Naoko
    Nakagawa, Saori
    Toda, Yuki
    Hosogi, Shigekuni
    Sato, Shinji
    Ashihara, Eishi
    ANTICANCER RESEARCH, 2023, 43 (02) : 547 - 555
  • [50] Targeting the mevalonate pathway, a novel anti-ferroptosis pathway, in hepatocellular carcinoma (HCC) treatment
    Chen, Yiling
    Lee, Derek
    Zhang, Misty Shuo
    Cheu, Jacinth Wing-Sum
    Wong, Carmen Chak-Lui
    CANCER RESEARCH, 2023, 83 (07)
12345